Declan Monaghan

Chief Financial Officer at ConserV Bioscience - london, ENG, UK

Declan Monaghan's Colleagues at ConserV Bioscience
Declan Monaghan's Contact Details
HQ
N/A
Location
London, England, United Kingdom
Company
ConserV Bioscience
Declan Monaghan's Company Details
ConserV Bioscience logo, ConserV Bioscience contact details

ConserV Bioscience

london, ENG, UK • 5 - 9 Employees
BioTech/Drugs

ConserV is a late-stage vaccine development company focused on advancing safe and effective vaccines that protect against endemic and emergent infectious diseases. We have a pipeline of eight vaccines in pre-clinical and clinical development including broad-spectrum influenza*, broad-spectrum coronavirus, mosquito-borne diseases*, HIV, Hepatitis C, Hepatitis B, Rotavirus and Chagas. ConserV's USP is the identification of antigens consisting of conserved regions of viral proteins containing a high number of REACTIVE T-cell epitopes with extensive HLA coverage.*Sub-licensed to Imutex Limited, a 51% owned subsidiary. hVIVO Services Limited own 49% of Imutex.

Biotechnology
Details about ConserV Bioscience
Frequently Asked Questions about Declan Monaghan
Declan Monaghan currently works for ConserV Bioscience.
Declan Monaghan's role at ConserV Bioscience is Chief Financial Officer.
Declan Monaghan's email address is ***@conservbio.com. To view Declan Monaghan's full email address, please signup to ConnectPlex.
Declan Monaghan works in the BioTech/Drugs industry.
Declan Monaghan's colleagues at ConserV Bioscience are and others.
Declan Monaghan's phone number is N/A
See more information about Declan Monaghan